Ototoxicity monitoring in children treated with platinum chemotherapy-Reference-Cited by-同舟云学术

Ototoxicity monitoring in children treated with platinum chemotherapy

Published:2017-07-24 Issue:sup4 Volume:57 Page:S62-S68
ISSN:1499-2027
Container-title:International Journal of Audiology
language:en
Short-container-title:International Journal of Audiology

Author:

Brooks Beth¹,Knight Kristin²

Affiliation:

1. Registered Audiologist, British Columbia's Children's Hospital, Vancouver, BC, Canada and

2. Department of Pediatric Audiology, Child Development and Rehabilitation Center, Doernbecher Children’s Hospital, Oregon Health and Science University, Portland, OR, USA

Publisher

Informa UK Limited

Subject

Speech and Hearing,Linguistics and Language,Language and Linguistics

Link

https://www.tandfonline.com/doi/pdf/10.1080/14992027.2017.1355570

Reference51 articles.

1. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy

2. Distortion product otoacoustic emission for the screening of cochlear damage in children treated with cisplatin

3. Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma

4. Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer

5. High-Frequency Pure-Tone Audiometry in Children: A Test–Retest Reliability Study Relative to Ototoxic Criteria

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ototoxicity among cisplatin, carboplatin, and oxaliplatin in zebrafish model;Environmental Toxicology;2024-04-25

2. Prevention of cisplatin-induced hearing loss in children: achievements and challenges for evidence-based implementation of sodium Thiosulfate;Frontiers in Oncology;2024-03-18

3. Reevaluation of sodium thiosulfate otoprotection using the consensus International Society of Paediatric Oncology Ototoxicity Scale: A report from the Children's Oncology Group study ACCL0431;Pediatric Blood & Cancer;2023-07-07

4. Pharmacological treatment with annexin A1-derived peptide protects against cisplatin-induced hearing loss;Toxicology Letters;2022-06

5. Supporting Cells and Their Potential Roles in Cisplatin-Induced Ototoxicity;Frontiers in Neuroscience;2022-04-27